EW vs NATL · P/E 47, rev $3.39B vs P/E 19, rev $1.15B
Edwards Lifesciences Corp (EW) versus NCR Atleos Corporation (NATL) — a side-by-side from cached financials, not a winner call.
Edwards Lifesciences Corp (EW) is a medical devices company listed on NYSE.
NCR Atleos Corporation (NATL) is a software - application company listed on US.
Latest reported EW revenue for 2026-06-30 was $3.39B. Net income was $622.6M. EW currently screens at market cap $49.91B and trailing P/E 46.9.
Latest reported NATL revenue for 2025-12-31 was $1.15B. Net income was $83.0M. Revenue was up 4.0% from 2024-12-31 to 2025-12-31. NATL currently screens at market cap $2.17B and trailing P/E 18.8.
EW currently screens at market cap $49.91B and trailing P/E 46.9. NATL currently screens at market cap $2.17B and trailing P/E 18.8.
Not investment advice. Open the EW and NATL stock pages for the full models.
Not investment advice.